摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(8R)-3-(2-deoxy-β-D-erythro-pentofuranosyl)-5-ethyl-3,6,7,8-tetrahydroimidazo<4,5-d><1,3>diazepin-8-ol | 86688-40-6

中文名称
——
中文别名
——
英文名称
(8R)-3-(2-deoxy-β-D-erythro-pentofuranosyl)-5-ethyl-3,6,7,8-tetrahydroimidazo<4,5-d><1,3>diazepin-8-ol
英文别名
(8R)-5-ethyl-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol
(8R)-3-(2-deoxy-β-D-erythro-pentofuranosyl)-5-ethyl-3,6,7,8-tetrahydroimidazo<4,5-d><1,3>diazepin-8-ol化学式
CAS
86688-40-6
化学式
C13H20N4O4
mdl
——
分子量
296.326
InChiKey
DRVSFKQXFDEPSX-YSSBGUOXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.6
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.69
  • 拓扑面积:
    112
  • 氢给体数:
    4
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    2-amino-1-(5-amino-1H-imidazol-4-yl)ethanone dihydrochloride 在 sodium tetrahydroborate 、 sodium methylate四氯化锡 作用下, 以 甲醇乙醇乙腈 为溶剂, 反应 7.08h, 生成 (8R)-3-(2-deoxy-β-D-erythro-pentofuranosyl)-5-ethyl-3,6,7,8-tetrahydroimidazo<4,5-d><1,3>diazepin-8-ol
    参考文献:
    名称:
    腺苷脱氨酶抑制剂。(+/-)-3,6,7,8-四氢-3-[(2-羟基乙氧基)甲基]咪唑[4,5-d] [1,3]二氮杂-8-ol的合成及生物学评价一些喷喷抑素的C-5同源物。
    摘要:
    (8R)-3-(2-deoxy-beta-D-erythro-pentto呋喃呋喃糖基)-3,6,7,8-四氢咪唑并[4,5-d] [1,3] diazepin-8的几种类似物的合成描述了-ol(戊抑素,1a)。用原乙酸三乙酯或原丙酸三乙酯将2-氨基-1-(5-氨基-1H-咪唑-4-基)乙酮二盐酸盐(3)闭环得到C-5甲基和乙基酮基糖苷酸6,7-二氢-5 -甲基咪唑并[4,5-d] [1,3]二氮杂8-8(3b)-和5-乙基-6,7-二氢咪唑并[4,5-d] [1,3]二氮杂8 (3H)-一个(4c)。氯化锡催化4b和4c的过三甲基甲硅烷基衍生物与受保护的糖基卤化物缩合,得到酮核苷3-(2-脱氧-3,5-二-Op-甲苯甲酰基-β-和-α-D-赤型-呋喃呋喃糖基)的端基异构体混合物)-6,7-二氢-5-甲基咪唑并[4,5-d] [1,3]二氮杂pin-8(3H)-one(5b和6b)和3-(
    DOI:
    10.1021/jm00364a022
点击查看最新优质反应信息

文献信息

  • Adenosine deaminase inhibitors. Synthesis and biological evaluation of (.+-.)-3,6,7,8-tetrahydro-3-[(2-hydroxyethoxy)methyl]imidazo[4,5-d][1,3]diazepin-8-ol and some selected C-5 homologs of pentostatin
    作者:H. D. Hollis Showalter、Sterling R. Putt、Pal E. Borondy、Joan L. Shillis
    DOI:10.1021/jm00364a022
    日期:1983.10
    methyl]imidazo[4,5-d][1,3]diazepin-8(3H)-one (9a) was followed by deprotection to 6,7-dihydro-3[(2-hydroxyethoxy)methyl]imidazo[4,5-d][1,3] diazepin-8(3H)-one (9b) and then reduction to the racemic acyclic pentostatin analogue (+/-)-3,6,7,8-tetrahydro-3-[ (2-hydroxyethoxy)methyl]imidazo[4,5-d][1,3]diazepin-8-ol (2). Ki values for the in vitro adenosine deaminase (EC 3.5.4.4; type I; calf intestinal mucosa) inhibitory
    (8R)-3-(2-deoxy-beta-D-erythro-pentto呋喃呋喃糖基)-3,6,7,8-四氢咪唑并[4,5-d] [1,3] diazepin-8的几种类似物的合成描述了-ol(戊抑素,1a)。用原乙酸三乙酯或原丙酸三乙酯将2-氨基-1-(5-氨基-1H-咪唑-4-基)乙酮二盐酸盐(3)闭环得到C-5甲基和乙基酮基糖苷酸6,7-二氢-5 -甲基咪唑并[4,5-d] [1,3]二氮杂8-8(3b)-和5-乙基-6,7-二氢咪唑并[4,5-d] [1,3]二氮杂8 (3H)-一个(4c)。氯化锡催化4b和4c的过三甲基甲硅烷基衍生物与受保护的糖基卤化物缩合,得到酮核苷3-(2-脱氧-3,5-二-Op-甲苯甲酰基-β-和-α-D-赤型-呋喃呋喃糖基)的端基异构体混合物)-6,7-二氢-5-甲基咪唑并[4,5-d] [1,3]二氮杂pin-8(3H)-one(5b和6b)和3-(
查看更多

同类化合物

脱氧助间型霉素 化合物RK-33 8-叔-丁基1-乙基6,7-二氢-5H-咪唑并[1,5-A][1,4]二氮杂卓-1,8(9H)-二甲酸基酯 8-(叔丁氧羰基)-6,7,8,9-四氢-5H-咪唑并[1,5-A][1,4]二氮杂-1-羧酸 6-羟基-4,5,6,7-四氢咪唑并[4,5-e][1,4]二氮杂卓-8(1H)-酮 5-(8-羟基-7,8-二氢-4H-咪唑并[5,4-d][1,3]二氮杂卓-3-基)-3-(羟基甲基)环戊-3-烯-1,2-二醇 4,7-二氢咪唑并[4,5-d][1,3]二氮杂卓-8(1H)-酮 3-[(2-羟基乙氧基)甲基]-3,4,7,8-四氢咪唑并[4,5-d][1,3]二氮杂卓-8-醇 1H-咪唑并[1,5-d〕〔1,4]二氮杂(9CI) 1,4,6,7-四氢咪唑并[4,5-e][1,4]二氮杂卓-5,8-二酮 (9ci)-1H-咪唑并[1,2-a][1,4]二氮杂卓 5-methylthio-11H-imidazo[1,2-c][1,3]benzodiazepine 2-methoxy-1,4,7-trimethyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione 1-benzyl-5,7-diphenyl-4,5,7,8-tetrahydroimidazo<4,5-e><1,3>diazepin-6-one 6-amino-4,5-dihydro-8H-imidazo[4,5-e][1,3]diazepine-4,8-dione [3-(2-Deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8 tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol]-5'-phosphoric Acid-(3-dodecylmercapto-2-decyloxy)-propyl Ester (4S)-4-benzyl-2-(2,5-dihydroxyphenyl)-3,4-dihydro-5H-pyrido[1',2':1,2]imidazo-[4,5-d][1,3]diazepin-5-one (4S)-4-benzyl-2-(2,5-dimethoxyphenyl)-3,4-dihydro-5H-pyrido[10,20:1,2]imidazo [4,5-d][1,3]diazepin-5-one (4S)-4-methyl-2-(1-naphthyl)-3,4-dihydro-5H-pyrido[1',2':1,2]imidazo-[4,5-d][1,3]diazepin-5-one 6-amino-1-(2'-deoxy-β-D-erythropentofuranosyl)-4,5-dihydro-8H-imidazo[4,5-e][1,3]diazepine-4,8-dione 6-amino-1-(2'-deoxy-α-D-erythropentofuranosyl)-4,5-dihydro-8H-imidazo[4,5-e][1,3]diazepine-4,8-dione (4S)-4-methyl-2-(4-acetamidophenyl)-3,4-dihydro-5H-pyrido[1',2':1,2]imidazo-[4,5-d][1,3]diazepin-5-one 5-(4-methyl-1-piperazinyl)-11H-imidazo[1,2-c][1,3]benzodiazepine monomaleate (8R)-3-[(4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol (R)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol 6-(decylamino)-1-[(2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7H-imidazo[4,5-e][1,3]diazepine-4,8-dione (13S)-11-(4-methoxyphenyl)-13-methyl-2,8,10,12-tetrazatricyclo[7.5.0.02,7]tetradeca-1(9),3,5,7,11-pentaen-14-one (8R)-3-[(2S,4S,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol 8-Ketodeoxycoformycin 2'-chloropentostatin CO-Vidarabine (8R)-3-[(1S,2R,4R)-2-(benzoyloxymethyl)-1-benzoyloxycyclopent-4-yl]-8-[(tert-butyldimethylsilyl)oxy]-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepine (8R)-3-Benzyl-6-(tert-butoxycarbonyl)-8-<(tert-butyldimethylsilyl)oxy>-3,6,7,8-tetrahydroimidazo<4,5-d><1,3>diazepine (8R)-3-(2'-Cyanoethyl)-8-<(tert-butyldimethylsilyl)oxy>-3,6,7,8-tetrahydroimidazo<4,5-d><1,3>diazepine 4-propyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione 1-benzyl-4-propyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione 4-isobutyl-7-methyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione 1-benzyl-4,7-diethyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione 1-benzyl-4-isobutyl-7-methyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione 4,6-diamino-6-(ethylimino)-1,6-dihydroimidazo[4,5-e][1,3]diazepine 4,5-dihydro-8H-6-(N-hexadecyl)amino-1-(2'-deoxy-α-D-erythropentofuranosyl)imidazo[4,5-e]diazepine-4,8-dione 4,5-dihydro-8H-6-(N-tetradecyl)amino-1-(2'-deoxy-α-D-erythropentofuranosyl)imidazo[4,5-e]diazepine-4,8-dione 4,5-dihydro-8H-6-(N-octadecyl)amino-1-(2-deoxy-α-D-erythropentofuranosyl)imidazo[4,5-e]diazepine-4,8-dione 4,6-diamino-6-(octadecylimino)-1,6-dihydroimidazo[4,5-e][1,3]diazepine 8-Imino-2,4-dimethyl-7-phenyl-7,8-dihydro-4H-1,2a,4,5,7-pentaaza-cyclopenta[cd]azulene-3,6-dione 1,4-dimethyl-4,5,7,8-tetrahydro-6H-imidazo<4,5-e><1,4>diazepine-5,8-dione 11H-imidazo[1,2-c][1,3]benzodiazepine-5(6H)-thione (8R)-3-[(4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol 2-(4-Chloro-benzylcarbamoyl)-6-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl)-hexanoic acid benzyl ester (13S)-13-(1H-indol-3-ylmethyl)-2,8,10,12-tetrazatricyclo[7.5.0.02,7]tetradeca-1(9),3,5,7-tetraene-11,14-dione